Example: Heart Attack

Clinical Trials on Anaplastic Astrocytoma

Total 384 results

NCT00003470

Completed

Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma

Conditions: Anaplastic Astrocytoma
NCT00841555

Completed

Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma

Conditions: Glioblastoma Multiforme/Anaplastic Astrocytoma
NCT00301418

Completed

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT00761280

Terminated

Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma

Conditions: Anaplastic Astrocytoma; Glioblastoma
NCT03528642

Recruiting

CB-839 With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma

Conditions: Anaplastic Astrocytoma, IDH-Mutant; Diffuse Astrocytoma, IDH-Mutant
NCT00606008

Completed

A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma

Conditions: Anaplastic Astrocytoma; Glioblastoma
NCT01386710

Suspended

Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT02796261

Recruiting

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Conditions: Anaplastic Astrocytoma; Recurrent Anaplastic Astrocytoma
NCT02022384

Recruiting

Immunophenotyping From Blood of Patients With Malignant Gliomas

Conditions: Anaplastic Astrocytoma; Glioblastoma Multiforme
NCT00115440

Completed

BNCT to Treat Glioma That Has Progressed Following Radiotherapy

Conditions: Glioblastoma; Anaplastic Astrocytoma
NCT03603405

Recruiting

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Conditions: Glioblastoma; Anaplastic Astrocytoma
NCT02414165

Terminated

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT01269853

Recruiting

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT01180816

Completed

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT00968240

Completed

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT00003537

Completed

Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma

Conditions: Adult Brain Tumor
NCT00003621

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma

Conditions: Brain and Central Nervous System Tumors
NCT00004259

Completed

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

Conditions: Brain and Central Nervous System Tumors
NCT00003775

Completed

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Conditions: Brain and Central Nervous System Tumors
NCT03022578

Completed

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Conditions: IDH Family Wildtype; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma
NCT00409214

Completed

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Conditions: Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT01238237

Completed

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

Conditions: Glioblastoma Multiforme (GBM); ANAPLASTIC ASTROCYTOMA (AOA); GBM; Anaplastic Astrocytoma
NCT00360828

Terminated

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Conditions: Astrocytoma; Glioma; Oligodendroglioma
NCT03224104

Recruiting

Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma

Conditions: Astrocytoma, Grade III; Glioblastoma
NCT02062827

Recruiting

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Conditions: Recurrent Glioblastoma Multiforme; Progressive Glioblastoma Multiforme; Anaplastic Astrocytoma or Gliosarcoma